Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Centocor Stories

2012-03-26 22:01:34

Results of the INFUSE-AMI trial presented at ACC.12 and published in JAMA Researchers have found that the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction, the most severe type of heart attack. Results of INFUSE-AMI trial were presented today at the American College of Cardiology's 61st Annual Scientific Session and published simultaneously in the March 25th online issue of the Journal of the American...

2012-02-28 08:02:00

NEW BRUNSWICK, N.J., Feb. 28, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen and Company 32nd Annual Health Care Conference on Tuesday, Mar. 6, at The Boston Marriott Copley Place. Dominic Caruso, Vice President, Finance & Chief Financial Officer will represent the Company in a session scheduled at 9:20 a.m. (Eastern Time). This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson...

2012-02-21 16:00:00

NEW BRUNSWICK, N.J., Feb. 21, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced that its Board of Directors has named Alex Gorsky Chief Executive Officer (CEO) of Johnson & Johnson effective April 26, 2012, the date of the Company's Annual Meeting of Shareholders. Mr. Gorsky was also nominated for election to the Board of Directors at the Annual Meeting. (Photo: http://photos.prnewswire.com/prnh/20120221/NY57240-a ) (Photo:...

2012-02-09 12:51:00

NEW BRUNSWICK, N.J., Feb. 9, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16, at The Waldorf Astoria in New York, N.Y. Sheri McCoy, Vice Chairman of the Executive Committee, will represent the Company in a session scheduled at 9:00 a.m. (Eastern Time). This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at...

2011-12-08 15:21:00

HORSHAM, Pa., Dec. 8, 2011 /PRNewswire-FirstCall/ -- Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ), announced today that it has executed an agreement with Pharmacyclics, Inc. (Nasdaq: PCYC) to jointly develop and market the anti-cancer compound, PCI-32765. A number of Phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma,...

2011-10-11 07:58:00

NEW BRUNSWICK, N.J., Oct. 11, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for financial analysts at 8:30 a.m. (Eastern Time) on Tuesday, October 18, 2011, to review third-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer, and Louise Mehrotra, Vice President, Investor Relations, will host the call. Investors and other interested parties may access the broadcast by visiting the Company's website at...

2011-09-28 15:10:00

FORT WASHINGTON, Pa., Sept. 28, 2011 /PRNewswire/ -- McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC (McNEIL) announced today that they have completed the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. joint venture in the United States from Merck Sharp & Dohme Corp. (Merck). The joint venture will be renamed McNeil Consumer Pharmaceuticals Co. and will continue to market products under the PEPCID®,...

2011-09-20 09:24:00

NEW BRUNSWICK, N.J., Sept. 20, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced important progress made in the inaugural year of the Company's comprehensive effort designed to improve the health of as many as 120 million women and children each year in developing countries by 2015. Since its launch last September, Johnson & Johnson has laid a strong foundation for measurable impact in several areas toward Every Woman, Every Child, the United Nations' Global...

2011-09-20 10:35:00

- Johnson & Johnson accepts 2011 Corporation of the Year Award during Million Dollar Club ceremony- WASHINGTON, Sept. 20, 2011 /PRNewswire-USNewswire/ -- The United States Hispanic Chamber of Commerce (USHCC) announced today that Johnson & Johnson is the 2011 Corporation of the Year at the 32nd Annual National Convention & Business Expo in Miami Beach, FL. Johnson & Johnson accepted the prestigious award during the Million Dollar Club Breakfast at the Miami Beach...

2011-09-06 13:15:00

NEW BRUNSWICK, N.J., Sept. 6, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley Global Health Care Conference Tuesday, September 13(th), at the Grand Hyatt New York, 109 East 42(nd) Street at Grand Central, New York, NY. Dominic Caruso, Vice President, Finance and Chief Financial Officer, Executive Committee for Johnson & Johnson, will represent the company in a session scheduled at 10:20 a.m. (Eastern). This broadcast will be available to...